Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BKCC

BlackRock Capital Investment (BKCC) Stock Price, News & Analysis

BlackRock Capital Investment logo

About BlackRock Capital Investment Stock (NASDAQ:BKCC)

Advanced Chart

Key Stats

Today's Range
$3.66
$3.70
50-Day Range
$3.62
$3.82
52-Week Range
$3.03
$4.03
Volume
162,805 shs
Average Volume
227,142 shs
Market Capitalization
$267.06 million
P/E Ratio
10.22
Dividend Yield
10.87%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BKCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Capital Investment and its competitors with MarketBeat's FREE daily newsletter.

BKCC Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
BlackRock Inc DRC (BLAK34)
See More Headlines

BKCC Stock Analysis - Frequently Asked Questions

BlackRock Capital Investment Co. (NASDAQ:BKCC) announced its quarterly earnings results on Monday, May, 1st. The asset manager reported $0.12 earnings per share for the quarter, beating analysts' consensus estimates of $0.11 by $0.01. The asset manager earned $18.76 million during the quarter, compared to analysts' expectations of $18.12 million. BlackRock Capital Investment had a net margin of 32.65% and a trailing twelve-month return on equity of 11.54%.
Read the conference call transcript
.

The following companies are subsidiaries of BlackRock Capital Investment: Summit Companies, National Renewable Solutions, Transaction Data Systems, Aquila Heywood, Aperio, eFront, Tennenbaum Capital Partners LLC, and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Capital Investment investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet (CLMT), Two Harbors Investments (TWO), NovoCure (NVCR), Rithm Capital (RITM) and Summit Midstream Partners (SMLP).

Company Calendar

Last Earnings
5/01/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Management consulting services
Sub-Industry
Asset Management & Custody Banks
Current Symbol
NASDAQ:BKCC
CIK
1326003
Employees
N/A
Year Founded
1988

Profitability

EPS (Trailing Twelve Months)
$0.36
Trailing P/E Ratio
10.22
Forward P/E Ratio
8.36
P/E Growth
N/A
Net Income
$26.24 million
Net Margins
32.65%
Pretax Margin
32.65%
Return on Equity
11.54%
Return on Assets
5.93%

Debt

Debt-to-Equity Ratio
0.93
Current Ratio
1.11
Quick Ratio
1.11

Sales & Book Value

Annual Sales
$80.36 million
Price / Sales
3.32
Cash Flow
$0.47 per share
Price / Cash Flow
7.84
Book Value
$4.35 per share
Price / Book
0.85

Miscellaneous

Outstanding Shares
72,570,000
Free Float
71,375,000
Market Cap
$267.06 million
Optionable
Optionable
Beta
1.41

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:BKCC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners